BioSpace News Archive

HYCOR Biomedical, a leading manufacturer of in vitro diagnostic products for allergy testing, and Changsha Haike Biotechnology Co., Ltd., its Chinese manufacturing partner, announced registration from Hunan Medical Products Administration (HMPA) for the ALLEOS 2000 allergy testing system on August 4, 2020 . “The registra

CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced the closing of its previously announced underwritten public offering of 12,300,000 units at a price to the public of $1.22 per unit. Each unit consists of one share of the Company’s common stock and one warrant to purchase 0.75 of a share of com

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today reported financial results for the quarter ended June 30, 2020. “Legend Biotech continues to execute on our corporate strategy, advancing the development of our lead product candidate, ciltacabtagene aut

Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the second quarter ended June 30, 2020. Second Quarter and First Half of 2020 Financial Summary Sales for the second quarter of 2020 were $52.3 million, a decrease of 18.3% from $64.0 million in the prior year period. Sales for the

Braingrid Limited is pleased to announce the appointment of Mr. Andrew Parks as the Company’s Interim Chief Executive Officer, who will lead a review of the Company’s business and potential strategic alternatives.

Movano Inc., a health-focused technology company dedicated to enhancing the quality of life for people affected by chronic health conditions, including diabetes, has closed its bridge round at $12.5M.

Atrium Health has passed a significant milestone in its Million Mask Initiative, announcing today it has now distributed more than 1 million free masks in the Charlotte regio

JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has chosen its bottling and labeling partner to support upcoming clinical trials

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration (“FDA”) has informed the Company that it needs additional time to complete its review of TLANDO’s New Drug Application (“NDA”) and is committed to taking ac

Xeris Pharmaceuticals, Inc. announced that on August 26, 2020, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 500 share of its common stock to 1 new employee under Xeris’ Inducement Equity Plan.